Although the impact of NF-kB has been described in several neurological disorders, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis [20], its role in SAH-induced DCI and neurologic outcome has not been explored in detail. The gene discussed is NFKB1; the disease is early-onset autosomal dominant Alzheimer disease.